Injection of new psychoactive substance snow blow associated with recently acquired hiv infections among homeless people who inject drugs in dublin, ireland, 2015

Eurosurveillance

Volumn 20, Issue 40, 2015, Pages

  Giese, C ^a,b   Igoe, D ^b   Gibbons, Z ^c   Hurley, C ^d   Stokes, S ^c   McNamara, S ^c   Ennis, O ^d   O'Donnell K ^b   Keenan, E ^c   De Gascun, C ^e,f   Lyons, F ^g   Ward, M ^d   Danis, K ^a,h   Glynn, R ^d   Waters, A ^e   Fitzgerald, M ^d  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^c HEALTH SERVICE EXECUTIVE   (Ireland)

^d Department of Public Health ^*  (Ireland)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

^g ST JAMES S HOSPITAL   (Ireland)

^h INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHINONE; PSYCHOTROPIC AGENT; ALPHA-PYRROLIDINOVALEROPHENONE; DESIGNER DRUG; PYRROLIDINE DERIVATIVE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; EPIDEMIC; FEMALE; HIV TEST; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; IRELAND; MALE; UNSAFE SEX; URINALYSIS; COMPLICATION; DRUG USE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK BEHAVIOR; HIV INFECTIONS; HOMELESS PERSON; INCIDENCE; MASS SPECTROMETRY; MIDDLE AGED; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; TRANSMISSION; URINE;

ADULT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIGNER DRUGS; DISEASE OUTBREAKS; DRUG USERS; FEMALE; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; INCIDENCE; IRELAND; MALE; MASS SPECTROMETRY; MIDDLE AGED; PSYCHOTROPIC DRUGS; PYRROLIDINES; RISK FACTORS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 85003043373     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2015.20.40.30036     Document Type: Article

References (23)

1. Glynn R, Giese C, Ennis O, Gibbons Z, O’Donnell K, Hurley C, et al. Increase in diagnoses of recently acquired HIV in people who inject drugs. Epi-Insight 2015 Jul; 16(7). Available from: http://ndsc.newsweaver.ie/epiinsight/1bumldnml2k?a=1&p=48942718&t=17517774
2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). EMCDDA–Europol Joint Report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1- pentanone (α-PVP). Lisbon: EMCDDA. Sep 2015. Available from: http://www.emcdda.europa.eu/publications/joint-reports/ alpha-pvp
3. De Gascun CF, Waters A, Regan CM, O’Halloran J, Farrell G, Coughlan S, et al. Human immunodeficiency virus type 1 in Ireland: phylogenetic evidence for risk group-specific subepidemics. AIDS Res Hum Retroviruses. 2012;28(9):1073-81. DOI: 10.1089/AID.2011.0301 PMID: 22176216
4. O’Byrne PM, Kavanagh PV, McNamara SM, Stokes SM. Screening of stimulants including designer drugs in urine using a liquid chromatography tandem mass spectrometry system.J Anal Toxicol. 2013;37(2):64-73. Available from: DOI: 10.1093/jat/bks091 PMID: 23316030
5. McNamara S, Stokes S, Shine Á, Kilduff R, O’Byrne P. New Psychoactive Substances Prevalence in Samples Tested in the NDTC Laboratory 2010-2015, Poster presented at European Network of Forensic Science Institutes (ENFSI) Drugs Conference 2015 (5th - 8th May 2015) in Dublin Castle, HSE National Drug Treatment Centre, Dublin, Ireland.
6. Van Hout MC, Bingham T. “A costly turn on”: patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. Int J Drug Policy. 2012;23(3):188-97. Available from: DOI: 10.1016/j.drugpo.2012.01.008 PMID: 22342322
7. Aarde SM, Creehan KM, Vandewater SA, Dickerson TJ, Taffe MA. In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology (Berl). 2015;232(16):3045-55. Available from: DOI: 10.1007/s00213- 015-3944-8 PMID: 25925780
8. Marusich J A, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH. Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology. 2014;87:206-13. Available from: DOI: 10.1016/j.neuropharm.2014.02.016 PMID: 24594476
9. Cameron KN, Kolanos R, Solis E, Glennon RA, De Felice LJ. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol. 2013;168(7):1750-7. Available from: DOI: 10.1111/bph.12061 PMID: 23170765
10. United Nations Office on Drugs and Crime (UNODC). FACTSHEET: “New psychoactive substances”. VIENNA: UNODC. [Accessed 1 Oct 2015]. Available from: https://www.unodc.org/documents/scientific/FACTSHEET_NPS.pdf
11. Watterson LR, Watterson E, Olive MF. Abuse liability of novel ‘legal high’ designer stimulants: evidence from animal models. Behav Pharmacol. 2013;24(5-6):341-55. Available from: DOI: 10.1097/FBP.0b013e3283641ec8 PMID: 23839028
12. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Perspective on drugs. Injection of synthetic cathinones. Lisbon: EMCDDA; 2014 May 27. Available from: http://www.emcdda.europa.eu/topics/pods/synthetic-cathinones-injection
13. An Garda Síochána. Annual Report of An Garda Síochána 2013. Dublin: An Garda Síochána. [Accessed: 1 Oct 2015]. Available from: http://www.garda.ie/Documents/User/Annual%20 Report%202013%20-%20English.pdf
14. Sypsa V, Paraskevis D, Malliori M, Nikolopoulos GK, Panopoulos A, Kantzanou M, et al. Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece. Am J Public Health. 2015;105(1):196-204. Available from: DOI: 10.2105/AJPH.2013.301656 PMID: 24524508
15. Barry J. Personal communication, Central Methadone Treatment List.
16. Dublin Region Homeless Executive. Performance Report 2015 relating to the protocol governing delegation of section 10 funding for homeless services to Dublin City Council, Q2 2015. Dublin: Dublin Region Homeless Executive. [Accessed 1 Oct 2015]. Available from: http://www.environ.ie/en/Publications/DevelopmentandHousing/Housing/FileDownLoad,42531,en.pdf
17. Hedrich D, Kalamara E, Sfetcu O, Pharris A, Noor A, Wiessing L, et al. Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe? Euro Surveill. 2013;18(48):20648. Available from: DOI: 10.2807/1560-7917.ES2013.18.48.20648 PMID: 24308980
18. Scotland HP. (HPS). Weekly Report News. Warning to drug injectors as HIV infections rise. Glasgow: HPS. 30 Jun 2015. Available from: http://www.hps.scot.nhs.uk/bbvsti/wrdetail. aspx?id=64359&wrtype=2#
19. Katchman E, Savyon M, Chemtob D, Avidor B, Mor O, Wasserman A, et al. An outbreak of primary HIV infection among injecting drug users in Tel Aviv, Israel, associated with changes in illicit drug use practices. 14th European AIDS Conference, Brussels. 2013.
20. Centers for Disease Control and Prevention (CDC), Conrad C, Bradley HM, Broz D, Buddha S, Chapman EL, Galang RR, et al. Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(16):443-4. PMID: 25928470
21. European Centre for Disease Prevention and Control (ECDC)/European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Thematic report: People who inject drugs. Monitoring implementation of the Dublin Declaration on Partnership to Figh HIVH/AIDS in Europe and Central Asia: 2014 progress report. Stockholm: ECDC; Sep 2015. Available from: http://ecdc.europa.eu/en/publications/Publications/dublin-declaration-people-who-inject-drugs.pdf
22. European Centre for Disease Prevention and Control (ECDC)/European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC; Oct 2011. Available from: http://ecdc.europa.eu/en/publications/Publications/111012_Guidance:ECDC-EMCDDA.pdf
23. European Monitoring Centre for Drugs and Drug Addiction. Drug-related infectious diseases in Europe: update from the EMCDDA expert network. Luxembourg: Publications Office of the European Union. 2015. Available from: http://www.emcdda. europa.eu/attachements.cfm/att_242420_EN_TD0215722ENN. pdf